Full-Time

Director – Channel Management

Posted on 8/29/2024

Alamar Biosciences

Alamar Biosciences

51-200 employees

Develops technology for protein detection and analysis

Biotechnology
Healthcare

Compensation Overview

$160k - $180kAnnually

+ Commission + Equity

Senior

Remote in USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Sales
Marketing
Data Analysis
Requirements
  • Bachelor’s degree in BSc/Commerce/Economics, master’s degree in business administration (preferred) or equivalent work experience
  • 15+ years of demonstrated experience in similar role with a strong focus on sales and channel development in life sciences and medical devices
  • Track record for achieving sales targets, AR collections, and partner recruitment and enablement
  • Ability to work closely with commercial and finance
  • Excellent knowledge and experience working with dealers and distributors in various geographic areas
  • Ability to put a business plan together based on data, analytics, and creative solutions to address opportunities
  • Excellent verbal and written communication skills and ability to interact with technical and business counterparts
Responsibilities
  • Create and drive channel strategy to reach business growth targets globally
  • Build annual plans and performance measures with channel partners
  • Implement scorecard and process for metrics; distribution, collection and ongoing quarterly performance monitoring
  • Structure sales training and marketing programs to drive partner effectiveness
  • Lead channel processes and workflows and maintains a successful business
  • Drive contract development process and negotiations, working with internal functions and external partners
  • Ensure legal and ethical compliance in business interactions

Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company's main product, NULISA™, allows for the detection and measurement of proteins in the human body with high sensitivity and a wide range. This technology is particularly useful for researchers and clinicians who need to profile and validate protein biomarkers, which can lead to the development of new diagnostic tests and treatments. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics, enabling users to analyze multiple protein targets in a single experiment. Unlike its competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it more accessible to clients. The company's goal is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options for various diseases.

Company Stage

Series C

Total Funding

$215.9M

Headquarters

Hayward, California

Founded

2018

Growth & Insights
Headcount

6 month growth

16%

1 year growth

46%

2 year growth

117%
Simplify Jobs

Simplify's Take

What believers are saying

  • Expansion into APAC and Europe enhances Alamar's global market presence.
  • Partnerships with ESYA Labs and MJFF boost Alamar's credibility in neurological research.
  • Alamar's technology supports early disease detection, a growing healthcare priority.

What critics are saying

  • Reliance on partnerships may limit Alamar's control over research outcomes.
  • High competition in proteomics could challenge Alamar's market position.
  • Regulatory changes could impact Alamar's operations and product approvals.

What makes Alamar Biosciences unique

  • Alamar's NULISA™ technology offers unprecedented sensitivity in protein detection.
  • The ARGO™ system automates high-throughput precision proteomics, reducing technical expertise requirements.
  • Alamar's ISO 13485 certification underscores its commitment to quality and safety.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE